News
PulseSight Therapeutics, an ophthalmology biotech company developing disruptive non-viral vectorized therapies with minimally-invasive delivery technology announces that its CSO, Thierry Bordet Ph.D., ...
Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent hearing loss disorders, today ...
Dolby Vision 2 brings AI-guided picture tuning, creator-driven motion, and a two-tier TV strategy, led by Hisense and CANAL+.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback